Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Reexamination Certificate
2005-01-11
2005-01-11
Spector, Lorraine (Department: 1647)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
C435S004000, C435S325000, C435S377000, C530S350000, C530S351000, C530S399000, C424S184100, C514S003100
Reexamination Certificate
active
06841386
ABSTRACT:
The present invention features methods of modulating primary stem cell differentiation in culture by altering the endogenous activity of an insulin-like growth factor.
REFERENCES:
patent: 5212074 (1993-05-01), Kiefer et al.
patent: 5527776 (1996-06-01), Carlino et al.
patent: 5643788 (1997-07-01), Baserga et al.
patent: 5837675 (1998-11-01), Brox
patent: 5973115 (1999-10-01), Clemmons et al.
patent: 6017885 (2000-01-01), Bagi et al.
patent: 6121416 (2000-09-01), Clark et al.
patent: 6274562 (2001-08-01), Baserga et al.
patent: WO 9508567 (1995-03-01), None
Arsenijevic et al. Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: distinct actions from those of brain-derived neurotrophic factor. J Neurosci. 18(6):2118-2128, 1998.*
Baxter, RC. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab. 278(6):E967-976, 2000.*
Drago et al. Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I. Proc Natl Acad Sci U S A. 88(6):2199-2203, 1991.*
Murphy, LJ. Insulin-like growth factor-binding proteins: functional diversity or redundancy? J Mol Endocrinol. 21(2):97-107, 1998.*
Pampusch et al. Effect of recombinant porcine IGF-binding protein-3 on proliferation of embryonic porcine myogenic cell cultures in the presence and absence of IGF-I. J Endocrinol. 176(2):227-235, 2003.*
Pell et al. Enhancement of insulin-like growth factor I activity by novel antisera: potential structure/function interactions. Endocrinology. 141(2):741-751, 2000.*
Spagnoli et al. Antiproliferative effects of insulin-like growth factor-binding protein-3 in mesenchymal chondrogenic cell line RCJ3.1C5.18. relationship to differentiation stage. J Biol Chem. 276(8):5533-5540, 2001.*
Grellier et al., “Characterization of Insulin-Like Growth Factor Binding Proteins (IGFBP) and Regulation of IGFBP-4 in Bone Marrow Stromal Cells,”British Journal of Haematology90:249-257 (1995).
Hansson et al., “Immunohistochemical Localization of Insulin-Like Growth Factor I in the Adult Rat,”Histochemistry89:403-410 (1988).
Hashimoto et al., “Binding Sites and Binding Properties of Binary and Ternary Complexes of Insulin-Like Growth Factor-II (IGF-II), IGF-Binding Protein-3, and Acid-Labile Subunit,”The Journal of Biological Chemistry272:27936-27942 (1997).
Hossner et al., “Insulin-Like Growth Factor (IGF)-I and -II and IGFPB Secretion by Ovine Satellite Cell Strains Grown Alone or in Coculture with 3T3-L1 Preadipocytes,”In Vitro Cell. Biol. Anim. 33:791-795 (1997).
Huang, S. and L. Terstappen, “Formation of Haematopoietic Microenvironment and Haematopoietic Stem Cells from Single Human Bone Marrow Stem Cells,”Nature360:745-749 (1992).
Hughes et al., “The Insulin-Like Growth Factors (IGFs) in Follicular Fluid are Predominantly Bound in the Ternary Complex,”Journal of Endocrinology. 155:R1-R4 (1997).
James et al., “Insulin-Like Growth Factor Binding Protein-5 Modulates Muscle Differentiation Through an Insulin-Like Growth Factor-Dependent Mechanism,”The Journal of Cell Biology133:683-693 (1996).
Kanatani et al., “Stimulatory Effect of Insulin-Like Growth Factor Binding Protein-5 on Mouse Osteoclast Formation and Osteoclastic Bone-Resorbing Activity,”Journal of Bone and Mineral Research15:902-910 (2000).
Lavranos et al., “Effects of Insulin-Like Growth Factors and Binding Protein 1 on Bovine Granulosa Cell Division in Anchorage-Independent Culture,”Journal of Reproduction and Fertility107:221-228 (1996).
Leal et al., “The Type V Transforming Growth Factor β Receptor is the Putative Insulin-Like Growth Factor-Binding Protein 3 Receptor,”The Journal of Biological Chemistry 272:20572-20576 (1997).
Li et al., “Regulation of Myeloid Growth and Differentiation by the Insulin-Like Growth Factor I Receptor,”Endocrinology138:362-368 (1997).
Long et al., “Involvement of Insulin-Like Growth Factor-1 and Its Binding Proteins in Proliferation and Differentiation of Murine Bone Marrow-Derived Macrophage Precursors,”Endocrine9:185-192 (1998).
Merchav et al., “Enhancement of Human Granulopoieses in Vitro by Biosynthetic Insulin-Like Growth Factor I/Somatomedin C and Human Growth Hormone,”J. Clin. Invest. 81:791-797 (1988).
Merchav et al., “Enhancement of Erythropoiesis in Vitro by Human Growth Hormone is Mediated by Insulin-Like Growth Factor I,”British Journal of Haematology70:267-271 (1988).
Merchav et al., “Comparative Studies of the Erythroid-Potentiating Effects of Biosynthetic Human Insulin-Like Growth Factors-I and -II,”Journal of Clinical Endocrinology and Metabolism74:447-452 (1992).
Merchav et al., “In-Vitro Response of Erythroid Progenitors from Children with Thalassaemia Major to Human Growth Hormone and Insulin-Like Growth Factor I,”Clinical Endocrinology39:207-211 (1993).
Merchav et al., “Comparative Studies of the Granulopoietic Enhancing Effects of Biosynthetic Human Insulin-Like Growth Factors I and II,”Journal of Cellular Physiology157:178-183 (1993).
Merchav, S., “The Haematopoietic Effects of Growth Hormone and Insulin-Like Growth Factor-I,”Journal of Pediatric Endocrinology And Metabolism11:677-685 (1998).
Rajah et al., “Insulin-Like Growth Factor (IGF)-Binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death Through a p53- and IGF-Independent Mechanism,”The Journal of Biological Chemistry. 272:12181-12188 (1997).
Stewart et al., “Overexpression of Insulin-Like Growth Factor-II induces Accelerated Myoblast Differentiation,”Journal of Cellular Physiology169:23-32 (1996).
Ueki et al., “Inactivation of the Acid Labile Subunit Gene in Mice Results in Mild Retardation of Postnatal Growth Despite Profound Disruptions in the Circulating Insulin-Like Growth Factor System,”Proc. Natl. Acad. Sci. USA97:6868-6873 (2000).
Zumkeller, W. and S. Burdach “The Insulin-Like Growth Factor System in Normal and Malignant Hematopoietic Cells,”Blood94:3653-3657 (1999).
Zumkeller, W., “The Role of Growth Hormone and Insulin-Like Growth Factors for Placental Growth and Development,”Placenta21:451-467 (2000).
Holman and Baxter, “Insulin-Like Growth Factor Binding Protein-3: Factors Affecting Binary and Ternary Complex Formation,”Growth Regulation6:42-47 (1996).
MacDonald et al., “Growth Inhibition and Differentiation of the Human Colon Carcinoma Cell Line, Caco-2, by Constitutive Expression of Insulin-like Growth Factor Binding Protein-3,” J.Gastroenterology and Hepatology14:72-78 (1999).
Deng Hongkui
Kraus Morey
Liu Liqin
Bunner Bridget E.
Clark Paul T.
Clark & Elbing LLP
Spector Lorraine
Viacell, Inc.
LandOfFree
Modulation of primary stem cell differentiation using an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of primary stem cell differentiation using an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of primary stem cell differentiation using an... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3404937